MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.570
+0.070 (4.67%)
At close: Mar 11, 2026, 4:00 PM EDT
1.552
-0.019 (-1.18%)
After-hours: Mar 11, 2026, 8:00 PM EDT
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $92.1 million as of March 11, 2026. Its market cap has increased by 94.52% in one year.
Market Cap
92.10M
Enterprise Value
81.20M
1-Year Change
94.52%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $92.10M, an increase of 80.22%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 87.99M | 50.29% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 93.43M |
| Kazia Therapeutics | 92.84M |
| aTyr Pharma | 91.76M |
| OKYO Pharma | 87.33M |
| PMV Pharmaceuticals | 86.39M |
| Spruce Biosciences | 86.15M |
| Pliant Therapeutics | 85.41M |
| Q32 Bio | 83.69M |